ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Laboratory Model for Heroin Abuse Medications - 8

This study is currently recruiting participants.
Study NCT00000273.   Last updated on October 28, 2008.   Information provided by National Institute on Drug Abuse (NIDA)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  A Laboratory Model for Heroin Abuse Medications - 8
Official Title  A Laboratory Model for Heroin Abuse Medications
Brief Summary

The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."

Detailed Description
Study Phase Phase II
Study Type  Interventional
Study Design  Treatment, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Placebo Control, Crossover Assignment, Pharmacodynamics Study
Primary Outcome Measure  Amount drug self-administered [ Time Frame: 90 minutes ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Subjective responses [ Time Frame: 90 min ] [ Designated as safety issue: No ]
Condition  Heroin Dependence
Opioid-Related Disorders
Substance-Related Disorders
Intervention  Drug: opiates
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  37
Start Date  August 1995
Completion Date June 2009
Eligibility Criteria 

Please contact site for information.

Gender Both
Ages 18 Years to 45 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Sandra D Comer, Ph.D.     212-543-5981     sdc10@columbia.edu    
Contact: Phillip Saccone, BS     212-543-5319     saccone@pi.cpmc.columbia.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00000273
Organization ID NIDA-09236-8
Secondary IDs †† P50-09236-8
Study Sponsor  National Institute on Drug Abuse (NIDA)
Collaborators †† New York State Psychiatric Institute
Investigators 
Principal Investigator:     Herbert Kleber, M.D.     New York State Psychiatric Institute    
Information Provided By National Institute on Drug Abuse (NIDA)
Verification Date October 2008
First Received Date  September 20, 1999
Last Updated Date October 28, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers